LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 22

Search options

  1. Article ; Online: Computational design of a cyclic peptide that inhibits the CTLA4 immune checkpoint.

    Thakkar, Ravindra / Upreti, Deepa / Ishiguro, Susumu / Tamura, Masaaki / Comer, Jeffrey

    RSC medicinal chemistry

    2023  Volume 14, Issue 4, Page(s) 658–670

    Abstract: Proteins involved in immune checkpoint pathways, such as CTLA4, PD1, and PD-L1, have become important targets for cancer immunotherapy; however, development of small molecule drugs targeting these pathways has proven difficult due to the nature of their ... ...

    Abstract Proteins involved in immune checkpoint pathways, such as CTLA4, PD1, and PD-L1, have become important targets for cancer immunotherapy; however, development of small molecule drugs targeting these pathways has proven difficult due to the nature of their protein-protein interfaces. Here, using a hierarchy of computational techniques, we design a cyclic peptide that binds CTLA4 and follow this with experimental verification of binding and biological activity, using bio-layer interferometry, cell culture, and a mouse tumor model. Beginning from a template excised from the X-ray structure of the CTLA4:B7-2 complex, we generate several peptide sequences using flexible docking and modeling steps. These peptides are cyclized head-to-tail to improve structural and proteolytic stability and screened using molecular dynamics simulation and MM-GBSA calculation. The standard binding free energies for shortlisted peptides are then calculated in explicit-solvent simulation using a rigorous multistep technique. The most promising peptide, cyc(EIDTVLTPTGWVAKRYS), yields the standard free energy -6.6 ± 3.5 kcal mol
    Language English
    Publishing date 2023-03-01
    Publishing country England
    Document type Journal Article
    ISSN 2632-8682
    ISSN (online) 2632-8682
    DOI 10.1039/d2md00409g
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Euglena gracilis

    Upreti, Deepa / Ishiguro, Susumu / Phillips, Morgan / Nakashima, Ayaka / Suzuki, Kengo / Comer, Jeffrey / Tamura, Masaaki

    Integrative cancer therapies

    2023  Volume 22, Page(s) 15347354231195323

    Abstract: ... Extracts ... ...

    Abstract Extracts from
    MeSH term(s) Mice ; Animals ; Carcinogens/toxicity ; Lung Neoplasms/chemically induced ; Lung Neoplasms/prevention & control ; Tobacco Smoke Pollution/adverse effects ; Euglena gracilis ; Gastrointestinal Microbiome ; Carcinogenesis/chemically induced ; Carcinoma
    Chemical Substances Carcinogens ; Tobacco Smoke Pollution
    Language English
    Publishing date 2023-08-30
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2182320-0
    ISSN 1552-695X ; 1534-7354
    ISSN (online) 1552-695X
    ISSN 1534-7354
    DOI 10.1177/15347354231195323
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Oral Administration of Water Extract from Euglena gracilis Alters the Intestinal Microbiota and Prevents Lung Carcinoma Growth in Mice

    Upreti, Deepa / Ishiguro, Susumu / Robben, Nicole / Nakashima, Ayaka / Suzuki, Kengo / Comer, Jeffrey / Tamura, Masaaki

    Nutrients. 2022 Feb. 05, v. 14, no. 3

    2022  

    Abstract: The antitumor effects of a partially purified water extract from Euglena gracilis (EWE) and EWE treated by boiling (bEWE) were evaluated using orthotopic lung cancer syngeneic mouse models with Lewis lung carcinoma (LLC) cells. Daily oral administration ... ...

    Abstract The antitumor effects of a partially purified water extract from Euglena gracilis (EWE) and EWE treated by boiling (bEWE) were evaluated using orthotopic lung cancer syngeneic mouse models with Lewis lung carcinoma (LLC) cells. Daily oral administration of either EWE or bEWE started three weeks prior to the inoculation of LLC cells significantly attenuated tumor growth as compared to the phosphate buffered saline (PBS) control, and the attenuation was further enhanced by bEWE. The intestinal microbiota compositions in both extract-treated groups were more diverse than that in the PBS group. Particularly, a decrease in the ratio of Firmicutes to Bacteroidetes and significant increases in Akkermansia and Muribaculum were observed in two types of EWE-treated groups. Fecal microbiota transplantation (FMT) using bEWE-treated mouse feces attenuated tumor growth to an extent equivalent to bEWE treatment, while tumor growth attenuation by bEWE was abolished by treatment with an antibiotic cocktail. These studies strongly suggest that daily oral administration of partially purified water extracts from Euglena gracilis attenuates lung carcinoma growth via the alteration of the intestinal microbiota.
    Keywords Bacteroidetes ; Euglena gracilis ; Firmicutes ; antibiotics ; feces ; intestinal microorganisms ; lung neoplasms ; mice ; oral administration ; phosphates
    Language English
    Dates of publication 2022-0205
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    ZDB-ID 2518386-2
    ISSN 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu14030678
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article ; Online: Oral Administration of Water Extract from

    Upreti, Deepa / Ishiguro, Susumu / Robben, Nicole / Nakashima, Ayaka / Suzuki, Kengo / Comer, Jeffrey / Tamura, Masaaki

    Nutrients

    2022  Volume 14, Issue 3

    Abstract: The antitumor effects of a partially purified water extract ... ...

    Abstract The antitumor effects of a partially purified water extract from
    MeSH term(s) Administration, Oral ; Animals ; Carcinoma ; Euglena gracilis ; Gastrointestinal Microbiome ; Lung ; Lung Neoplasms/prevention & control ; Mice ; Water/pharmacology
    Chemical Substances Water (059QF0KO0R)
    Language English
    Publishing date 2022-02-05
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2518386-2
    ISSN 2072-6643 ; 2072-6643
    ISSN (online) 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu14030678
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Local immune checkpoint blockade therapy by an adenovirus encoding a novel PD-L1 inhibitory peptide inhibits the growth of colon carcinoma in immunocompetent mice.

    Ishiguro, Susumu / Upreti, Deepa / Bassette, Molly / Singam, E R Azhagiya / Thakkar, Ravindra / Loyd, Mayme / Inui, Makoto / Comer, Jeffrey / Tamura, Masaaki

    Translational oncology

    2022  Volume 16, Page(s) 101337

    Abstract: A novel peptide that interferes with the PD-1/PD-L1 immune checkpoint pathway, termed PD-L1 inhibitory peptide 3 (PD-L1ip3), was computationally designed, experimentally validated for its specific binding to PD-L1, and evaluated for its antitumor effects ...

    Abstract A novel peptide that interferes with the PD-1/PD-L1 immune checkpoint pathway, termed PD-L1 inhibitory peptide 3 (PD-L1ip3), was computationally designed, experimentally validated for its specific binding to PD-L1, and evaluated for its antitumor effects in cell culture and in a mouse colon carcinoma syngeneic murine model. In several cell culture studies, direct treatment with PD-L1ip3, but not a similar peptide with a scrambled sequence, substantially increased death of CT26 colon carcinoma cells when co-cultured with murine CD8
    Language English
    Publishing date 2022-01-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2443840-6
    ISSN 1936-5233
    ISSN 1936-5233
    DOI 10.1016/j.tranon.2021.101337
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: A Water Extract from Chlorella sorokiniana Cell Walls Stimulates Growth of Bone Marrow Cells and Splenocytes

    Ishiguro, Susumu / Roth, Mary / Welti, Ruth / Loyd, Mayme / Thakkar, Ravindra / Phillips, Morgan / Robben, Nicole / Upreti, Deepa / Nakashima, Ayaka / Suzuki, Kengo / Comer, Jeffrey / Tamura, Masaaki

    Nutrients. 2022 July 15, v. 14, no. 14

    2022  

    Abstract: A water extract derived from the isolated cell walls of Chlorella sorokiniana (C. sorokiniana, Chlorella water extract, CWE) was analyzed for the presence of lipopolysaccharide (LPS)-related material via the Limulus amebocyte lysate (LAL) assay and ... ...

    Abstract A water extract derived from the isolated cell walls of Chlorella sorokiniana (C. sorokiniana, Chlorella water extract, CWE) was analyzed for the presence of lipopolysaccharide (LPS)-related material via the Limulus amebocyte lysate (LAL) assay and evaluated for its growth stimulation effect on the bone marrow cells and splenocytes in vitro cell cultures. The extract contained low levels of LPS-related material, and a mass spectrum suggested that the extract contained many components, including a low level of a lipid A precursor, a compound known as lipid X, which is known to elicit a positive response in the LAL assay. Treatment with the CWE dose- and time-dependently stimulated the growth of mouse bone marrow cells (BMCs) and splenocytes (SPLs). Treatment with the CWE also increased specific BMC subpopulations, including antigen-presenting cells (CD19⁺ B cells, 33D1⁺ dendritic cells and CD68⁺ macrophages), and CD4⁺ and CD8⁺ T cells, but decreased the number of LY6G⁺ granulocytes. Treatment with the CWE also increased cytokine mRNA associated with T cell activation, including TNFα, IFNγ, and granzyme B in human lymphoblasts. The present study indicates that the cell wall fraction of C.sorokiniana contains an LPS-like material and suggests a candidate source for the bioactivity that stimulates growth of both innate and adaptive immune cells.
    Keywords Chlorella sorokiniana ; bioactive properties ; bone marrow ; cell walls ; granulocytes ; humans ; lipid A ; macrophages ; mice ; splenocytes
    Language English
    Dates of publication 2022-0715
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    ZDB-ID 2518386-2
    ISSN 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu14142901
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article ; Online: De novo

    Thakkar, Ravindra / Agarwal, Dilip K / Ranaweera, Chathuranga B / Ishiguro, Susumu / Conda-Sheridan, Martin / Gaudreault, Natasha N / Richt, Juergen A / Tamura, Masaaki / Comer, Jeffrey

    RSC medicinal chemistry

    2023  Volume 14, Issue 9, Page(s) 1722–1733

    Abstract: Although effective vaccines have been developed against SARS-CoV-2, many regions in the world still have low rates of vaccination and new variants with mutations in the viral spike protein have reduced the effectiveness of most available vaccines and ... ...

    Abstract Although effective vaccines have been developed against SARS-CoV-2, many regions in the world still have low rates of vaccination and new variants with mutations in the viral spike protein have reduced the effectiveness of most available vaccines and treatments. There is an urgent need for a drug to cure this disease and prevent infection. The SARS-CoV-2 virus enters the host cell through protein-protein interaction between the virus's spike protein and the host's angiotensin converting enzyme (ACE2). Using protein design software and molecular dynamics simulations, we have designed a 17-residue peptide (pep39), that binds to the spike protein receptor-binding domain (RBD) and blocks interaction of spike protein with ACE2. We have confirmed the binding activity of the designed peptide for the original spike protein and the delta variant spike protein using micro-cantilever and bio-layer interferometry (BLI) based methods. We also confirmed that pep39 strongly inhibits SARS-CoV-2 virus replication in Vero E6 cells. Taken together these data suggest that a newly designed spike protein RBD blocking peptide pep39 has a potential as a SARS-CoV-2 virus inhibitor.
    Language English
    Publishing date 2023-07-31
    Publishing country England
    Document type Journal Article
    ISSN 2632-8682
    ISSN (online) 2632-8682
    DOI 10.1039/d3md00222e
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A Water Extract from

    Ishiguro, Susumu / Roth, Mary / Welti, Ruth / Loyd, Mayme / Thakkar, Ravindra / Phillips, Morgan / Robben, Nicole / Upreti, Deepa / Nakashima, Ayaka / Suzuki, Kengo / Comer, Jeffrey / Tamura, Masaaki

    Nutrients

    2022  Volume 14, Issue 14

    Abstract: A water extract derived from the isolated cell walls ... ...

    Abstract A water extract derived from the isolated cell walls of
    MeSH term(s) Animals ; Bone Marrow Cells ; CD8-Positive T-Lymphocytes ; Cell Wall ; Chlorella ; Humans ; Lipopolysaccharides ; Mice ; Spleen ; Water
    Chemical Substances Lipopolysaccharides ; Water (059QF0KO0R)
    Language English
    Publishing date 2022-07-15
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2518386-2
    ISSN 2072-6643 ; 2072-6643
    ISSN (online) 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu14142901
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Beta-1,3 Oligoglucans Specifically Bind to Immune Receptor CD28 and May Enhance T Cell Activation.

    Comer, Jeffrey / Bassette, Molly / Burghart, Riley / Loyd, Mayme / Ishiguro, Susumu / Azhagiya Singam, Ettayapuram Ramaprasad / Vergara-Jaque, Ariela / Nakashima, Ayaka / Suzuki, Kengo / Geisbrecht, Brian V / Tamura, Masaaki

    International journal of molecular sciences

    2021  Volume 22, Issue 6

    Abstract: Beta glucans are known to have immunomodulatory effects that mediated by a variety of mechanisms. In this article, we describe experiments and simulations suggesting that beta-1,3 glucans may promote activation of T cells by a previously unknown ... ...

    Abstract Beta glucans are known to have immunomodulatory effects that mediated by a variety of mechanisms. In this article, we describe experiments and simulations suggesting that beta-1,3 glucans may promote activation of T cells by a previously unknown mechanism. First, we find that treatment of a T lymphoblast cell line with beta-1,3 oligoglucan significantly increases mRNA levels of T cell activation-associated cytokines, especially in the presence of the agonistic anti-CD3 antibody. This immunostimulatory activity was observed in the absence of dectin-1, a known receptor for beta-1,3 glucans. To clarify the molecular mechanism underlying this activity, we performed a series of molecular dynamics simulations and free-energy calculations to explore the interaction of beta-1,3 oligoglucans with potential immune receptors. While the simulations reveal little association between beta-1,3 oligoglucan and the immune receptor CD3, we find that beta-1,3 oligoglucans bind to CD28 near the region identified as the binding site for its natural ligands CD80 and CD86. Using a rigorous absolute binding free-energy technique, we calculate a dissociation constant in the low millimolar range for binding of 8-mer beta-1,3 oligoglucan to this site on CD28. The simulations show this binding to be specific, as no such association is computed for alpha-1,4 oligoglucan. This study suggests that beta-1,3 glucans bind to CD28 and may stimulate T cell activation collaboratively with T cell receptor activation, thereby stimulating immune function.
    MeSH term(s) CD28 Antigens/chemistry ; CD28 Antigens/metabolism ; Cytokines/metabolism ; Humans ; Jurkat Cells ; Lymphocyte Activation/immunology ; Models, Molecular ; Protein Binding ; Receptors, Immunologic/chemistry ; Receptors, Immunologic/metabolism ; T-Lymphocytes/immunology ; Thermodynamics ; beta-Glucans/chemistry ; beta-Glucans/metabolism
    Chemical Substances CD28 Antigens ; Cytokines ; Receptors, Immunologic ; beta-Glucans
    Language English
    Publishing date 2021-03-18
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms22063124
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Combined Local Pulmonary and Systemic Delivery of AT2R Gene by Modified TAT Peptide Nanoparticles Attenuates Both Murine and Human Lung Carcinoma Xenografts in Mice.

    Ishiguro, Susumu / Alhakamy, Nabil A / Uppalapati, Deepthi / Delzeit, Jennifer / Berkland, Cory J / Tamura, Masaaki

    Journal of pharmaceutical sciences

    2017  Volume 106, Issue 1, Page(s) 385–394

    Abstract: To evaluate the potential of cell-penetrating peptide-based delivery of apoptosis-inducer gene in cancer therapy, a modified HIV-1 TAT peptide (dimerized TAT peptide, dTAT) was studied. The dTAT and plasmid DNA (pDNA) complexes (dTAT-pDNA) were condensed ...

    Abstract To evaluate the potential of cell-penetrating peptide-based delivery of apoptosis-inducer gene in cancer therapy, a modified HIV-1 TAT peptide (dimerized TAT peptide, dTAT) was studied. The dTAT and plasmid DNA (pDNA) complexes (dTAT-pDNA) were condensed using calcium chloride (dTAT-pDNA-Ca
    Language English
    Publishing date 2017-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3151-3
    ISSN 1520-6017 ; 0022-3549
    ISSN (online) 1520-6017
    ISSN 0022-3549
    DOI 10.1016/j.xphs.2016.08.023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top